Published 2022
| Version v1
Publication
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
Contributors
Description
The Coronavirus 19 pandemic has raised new relevant questions regarding the management of patients with multiple sclerosis (pwMS) treated with different immunosuppressive and immunomodulant drugs. In most COVID-19 outcomes analyses, due to the small available sample size, patients treated with cladribine were grouped with patients treated with other treatments.
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/1098103
- URN
- urn:oai:iris.unige.it:11567/1098103
Origin repository
- Origin repository
- UNIGE